Progenity, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Progenity, Inc. | PROG - NASDAQ |
$14.00-$16.00 | $15.00 | $15.11 | 6.66 million | 6/19/2020 |
| Piper Sandler, Wells Fargo Securities | ||||||
Co-Manager(s): Baird, Raymond James, BTIG | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-05-27 Terms Added 2020-06-15 | ||||||
Progenity, Inc. Quote & Chart - Click for current quote - PROG
IPO Boutique aggregates information on public companies and private companies, such as "PROG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Progenity, Inc. (adapted from Progenity, Inc. prospectus):
They are a biotechnology company with an established track record of success in developing and commercializing molecular testing products as well as innovating in the field of precision medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a biotechnology company with an established track record of success in developing and commercializing molecular testing products as well as innovating in the field of precision medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "PROG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.